Goldman Sachs Downgrades Gentex to Sell, Lowers Price Target to $20

Benzinga Newsdesk www.benzinga.com Negative 94.2%

Neg 94.2% Neu 0% Pos 0%

Goldman Sachs analyst Mark Delaney downgrades Gentex (NASDAQ:GNTX) from Neutral to Sell and lowers the price target from $23 to $20.